Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Scientists discover new pathway that allows better identification of bowel cancer patients most likely to benefit from monoclonal antibody therapy EGFR monoclonal antibodies are only effective in treating bowel cancer in half of the patients entering clinical trials. This new study has identified the tumour suppressor TSPAN6 as a critical biomarker that can be used to predict responses and select the most suitable candidates for therapy.
Posted 21 January 2022 New blood cancer gene defect can be treated with existing drugs A defective gene normally found in blood cancers could be treated with drugs already available for cancers with similar gene defects, scientists reveal.
Posted 20 December 2021 University of Birmingham announces five new diabetes research studies The University of Birmingham today announces the launch of five new major studies aimed at improving the prevention, treatment and management of type 1 diabetes – with a particular focus on children and young adults.
Posted 20 December 2021 Omicron may cause 100,000 cancelled operations in England this winter An additional 100,000 elective operations could be cancelled in England this winter as a result of the Omicron wave leading to increased hospital admissions, a new study reveals.